Ziltivekimab Antibody
Ziltivekimab (MEDI 5117) is a humanized monoclonal antibody produced in CHO cells, designed to target and neutralize interleukin-6 (IL-6) . It is a research tool for investigating IL-6-mediated pathways in autoimmune and inflammatory diseases, with utility in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
IL-6, ILReceptor, IL Receptor, Interleukin Related, MEDI 5117, MEDI5117, EX6018, EX-6018, COR001, COR-001, WBP216, WBP-216
Target
IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
9.26 mg/mL
Purity
97.20% (May vary between batches)
Molecular Weight
145.39 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
OR10G2, NT (OR10G2, Olfactory receptor 10G2) (MaxLight 750)
OR10G2, NT (OR10G2, Olfactory receptor 10G2) (MaxLight 750)
Recombinant Salmonella agona Regulator of ribonuclease activity A (rraA)
Recombinant Salmonella agona Regulator of ribonuclease activity A (rraA)
Recombinant Salmonella agona Regulator of ribonuclease activity A (rraA)